Sylvie Burnouf
- Physiology top 5%
- Cellular and Molecular Neuroscience top 10%
- Molecular Biology
- Neurology top 10%
- Pharmacology top 10%
- Co-authors
- David BlumLuc BuéeJacqueline DolsLinda PartridgeDominique DemeyerKarim BélarbiMalika HamdaneMarie‐Eve Grosjean
- Topics
- Alzheimer's disease research and treatments (14 papers)Cholinesterase and Neurodegenerative Diseases (6 papers)Neuroscience and Neuropharmacology Research (5 papers)
- Partner nations
- FranceGermanyUnited Kingdom
In The Last Decade
Sylvie Burnouf
19 papers receiving 722 citations
Peers
Comparison fields: 5 of 86
- Physiology 399
- Cellular and Molecular Neuroscience 263
- Molecular Biology 213
- Neurology 130
- Pharmacology 120
Countries citing papers authored by Sylvie Burnouf
This map shows the geographic impact of Sylvie Burnouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Burnouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Burnouf more than expected).
Fields of papers citing papers by Sylvie Burnouf
This network shows the impact of papers produced by Sylvie Burnouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Burnouf. The network helps show where Sylvie Burnouf may publish in the future.
Co-authorship network of co-authors of Sylvie Burnouf
This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Burnouf. A scholar is included among the top collaborators of Sylvie Burnouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Burnouf. Sylvie Burnouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 62 | |
| 3 | 34 | |
| 4 | 37 | |
| 5 | 28 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 34 | |
| 9 | 80 | |
| 10 | 57 | |
| 11 | 10 | |
| 12 | 27 | |
| 13 | 29 | |
| 14 | 4 | |
| 15 | 73 | |
| 16 | 85 | |
| 17 | 47 | |
| 18 | 38 | |
| 19 | 50 |
About Sylvie Burnouf
Sylvie Burnouf is a scholar working on Biological Psychiatry, Physiology and Cellular and Molecular Neuroscience, having authored 19 papers that have together received 728 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (14 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). The work is most often cited by research in Biological Psychiatry (45 citations), Neurology (130 citations) and Physiology (399 citations). Sylvie Burnouf has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include David Blum, Luc Buée, Jacqueline Dols, Linda Partridge, Dominique Demeyer, Karim Bélarbi, Malika Hamdane, Marie‐Eve Grosjean, Laëtitia Troquier and Raphaëlle Caillierez. Their work appears in journals such as Diabetes, Scientific Reports and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.